Monica Racovita
Research Subjects
Monica Racovita has a total of 66 co-authors. Here are the top co-authors by number of shared publications:
- Anne-Marie Baird
Trinity College Dublin
2 shared publications - Armin Spök
Science, Technology and Society Unit, Graz University of Technology, Graz, Austria
2 shared publications Eleanor Wheeler
The Health Policy Partnerships, 68-69 St Martin's Lane, London WC2N 4JS, United Kingdom
2 shared publications- Albina Hyseni-Bocolli1 shared publication
Ananda Plate
1 shared publicationAnna Bögös
1 shared publication
Latest Publications
- Open Access
- 14 May 2026
- Published by Elsevier in Blood Global Hematology
- Vol. 2 (3)
Variation in use of PROMs and geographical distribution in clinical trials of selected hematological diseases in Europe
- 14 May 2026
- Published by Elsevier in Blood Global Hematology
- Vol. 2 (3)
Open AccessVariation in use of PROMs and geographical distribution in clinical trials of selected hematological diseases in Europe
- Open Access
- 8 September 2022
- Published by Elsevier in European Journal of Cancer
- Vol. 175, 54-59
The need for a comprehensive and integrated approach to lung cancer policy in Europe
- 8 September 2022
- Published by Elsevier in European Journal of Cancer
- Vol. 175, 54-59
Open AccessThe need for a comprehensive and integrated approach to lung cancer policy in Europe
- Open Access
- 9 August 2022
- Published by Taylor & Francis in GM Crops & Food
- Vol. 13 (1) , 142-155
Strategic science translation in emerging science: genetically modified crops and Bisphenol A in two cases of contested animal toxicity studies
When controversies develop around scientific facts or technologies, the potential of science to become a tool in plays of interests and power between different actors is not well recognized. Cordner’s concept of Strategic Science Translation (SST) shows that such actions are enabled by the uncertainty and the complexity of the scientific processes that allow the use of science in support of various, often contradictory interests and goals. Two high-profile controversies around animal toxicity studies in two different fields of European regulatory science (genetically modified food and food contact materials) were chosen as case studies to explore and expand the SST concept. Both studies involve emerging science issues, emphasizing tensions between regulatory and academic science. Communications from key Civil Society Organizations (CSOs) and industry groups were used for analysis of each controversy. We found that both groups of actors try to present their own interpretation of scientific results, taking advantage of the lack of scientific consensus, of the uncertainties associated with the negotiation in the interpretation of results, and of the wider scientific and political context. In the same time, each actor attempts to challenge the credibility of the other. The lack of formal acknowledgment of the limitations of the emerging scientific fields, as well as of different research approaches between regulatory and academic research contribute to the continuation of controversies in the public domain, as the public cannot easily assess the information presented.
- 9 August 2022
- Published by Taylor & Francis in GM Crops & Food
- Vol. 13 (1) , 142-155
Open AccessStrategic science translation in emerging science: genetically modified crops and Bisphenol A in two cases of contested animal toxicity studies
When controversies develop around scientific facts or technologies, the potential of science to become a tool in plays of interests and power between different actors is not well recognized. Cordner’s concept of Strategic Science Translation (SST) shows that such actions are enabled by the uncertainty and the complexity of the scientific processes that allow the use of science in support of various, often contradictory interests and goals. Two high-profile controversies around animal toxicity studies in two different fields of European regulatory science (genetically modified food and food contact materials) were chosen as case studies to explore and expand the SST concept. Both studies involve emerging science issues, emphasizing tensions between regulatory and academic science. Communications from key Civil Society Organizations (CSOs) and industry groups were used for analysis of each controversy. We found that both groups of actors try to present their own interpretation of scientific results, taking advantage of the lack of scientific consensus, of the uncertainties associated with the negotiation in the interpretation of results, and of the wider scientific and political context. In the same time, each actor attempts to challenge the credibility of the other. The lack of formal acknowledgment of the limitations of the emerging scientific fields, as well as of different research approaches between regulatory and academic research contribute to the continuation of controversies in the public domain, as the public cannot easily assess the information presented.
- Open Access
- 15 February 2022
- Published by European Publishing in Tobacco Prevention & Cessation
- Vol. 8 (February) , 1-2
Lung cancer in Europe: The way forward
- 15 February 2022
- Published by European Publishing in Tobacco Prevention & Cessation
- Vol. 8 (February) , 1-2
Open AccessLung cancer in Europe: The way forward
- Open Access
- 24 April 2020
- Published by Springer Nature in Archives of Toxicology
- Vol. 94 (5) , 1779-1781
Correction to: Lack of adverse effects in subchronic and chronic toxicity/carcinogenicity studies on the glyphosate-resistant genetically modified maize NK603 in Wistar Han RCC rats
In the original publication, the starting point in time for the three feeding trials.
- 24 April 2020
- Published by Springer Nature in Archives of Toxicology
- Vol. 94 (5) , 1779-1781
Open AccessCorrection to: Lack of adverse effects in subchronic and chronic toxicity/carcinogenicity studies on the glyphosate-resistant genetically modified maize NK603 in Wistar Han RCC rats
In the original publication, the starting point in time for the three feeding trials.